Index of reports
> Cases with Myelodysplastic Syndrome (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thalomid (Thalidomide) where reactions include myelodysplastic syndrome. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Thalomid side effects in 73 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: 73 year old male, weighing 104.6 kg (230.1 pounds)
Reactions: Renal Failure, Sepsis, Myelodysplastic Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: 100 milligram
Administration route: Oral
Start date: 2008-09-04
End date: 2009-12-14
Melphalan Hydrochloride
Dosage: 9 milligram/sq. meter
Start date: 2008-09-04
End date: 2009-12-14
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-21
Prednisone TAB
Dosage: 100 milligram
Start date: 2008-09-04
End date: 2009-12-14
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-04-19
End date: 2011-07-26
Other drugs received by patient: Dexamethasone; Simvastatin; Garlic; Dilaudid; Pseudoephedrine HCL; Loperamide; Proair HFA; Talwin NX; Vitamin D; Ambien; Duragesic-100; Antacid Medicine (Homeopathic); MS Contin; Vitamin E; Magnesium Oxide; Aspirin; Neupogen; Miralax; Vitamin B-12
Possible Thalomid side effects in 73 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: 73 year old male, weighing 104.6 kg (230.1 pounds)
Reactions: Renal Failure, Sepsis, Myelodysplastic Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: 9 milligram/sq. meter
Start date: 2008-09-04
End date: 2009-12-14
Prednisone TAB
Dosage: 100 milligram
Start date: 2008-09-04
End date: 2009-12-14
Thalomid
Dosage: 100 milligram
Administration route: Oral
Start date: 2008-09-04
End date: 2009-12-14
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-21
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-04-19
End date: 2011-07-26
Other drugs received by patient: Antacid Medicine (Homeopathic); Aspirin; Loperamide; Garlic; Miralax; Ambien; Dilaudid; Vitamin E; Simvastatin; Proair HFA; Duragesic-100; Dexamethasone; Neupogen; Vitamin B-12; Vitamin D; Talwin NX; MS Contin; Pseudoephedrine HCL; Magnesium Oxide
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-07-06
Patient: female
Reactions: Neuropathy Peripheral, Myelodysplastic Syndrome, Breast Cancer in Situ, Deep Vein Thrombosis
Drug(s) suspected as cause:
Thalomid
Other drugs received by patient: Etoposide; Dexamethasone Sodium Phosphate; Cyclophosphamide; Velcade; Neupogen; Cisplatin
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-07-02
Patient: female
Reactions: Neuropathy Peripheral, Myelodysplastic Syndrome, Breast Cancer in Situ, Deep Vein Thrombosis
Drug(s) suspected as cause:
Thalomid
Other drugs received by patient: Neupogen; Cisplatin; Cyclophosphamide; Velcade; Dexamethasone; Etoposide
Possible Thalomid side effects in 73 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15
Patient: 73 year old male, weighing 104.6 kg (230.1 pounds)
Reactions: Renal Failure, Sepsis, Myelodysplastic Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: 100 milligram
Administration route: Oral
Start date: 2008-09-04
End date: 2009-12-14
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-04-19
End date: 2011-07-26
Melphalan Hydrochloride
Dosage: 9 milligram/sq. meter
Start date: 2008-09-04
End date: 2009-12-14
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-21
Prednisone
Dosage: 100 milligram
Start date: 2008-09-04
End date: 2009-12-14
Other drugs received by patient: Loperamide; Aspirin; Dexamethasone; Duragesic-100; Vitamin B-12; Proair HFA; Garlic; Miralax; Vitamin E; Pseudoephedrine HCL; Dilaudid; Neupogen; Talwin NX; Antacid Medicine (Homeopathic); Vitamin D; MS Contin; Simvastatin; Magnesium Oxide; Ambien
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-06-12
Patient: female
Reactions: Neuropathy Peripheral, Myelodysplastic Syndrome, Breast Cancer in Situ, Deep Vein Thrombosis
Drug(s) suspected as cause:
Thalomid
Other drugs received by patient: Velcade; Cyclophosphamide; Dexamethasone; Cisplatin; Etoposide; Neupogen
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-05-09
Patient: female
Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: unknown
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2003-03-01
Thalomid
Dosage: 100 milligram
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2012-01-01
Other drugs received by patient: Zometa; Dexamethasone; Decadron
Possible Thalomid side effects in 73 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02
Patient: 73 year old male, weighing 104.6 kg (230.1 pounds)
Reactions: Myelodysplastic Syndrome
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: 9 milligram/sq. meter
Start date: 2008-09-04
End date: 2009-12-14
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-21
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-04-19
End date: 2011-07-26
Thalomid
Dosage: 100 milligram
Administration route: Oral
Start date: 2008-09-04
End date: 2009-12-14
Prednisone
Dosage: 100 milligram
Start date: 2008-09-04
End date: 2009-12-14
Other drugs received by patient: Duragesic-100; Antacid Medicine (Homeopathic); Vitamin D; Talwin NX; Dexamethasone; Proair HFA; Neupogen; Loperamide; Simvastatin; Garlic; Miralax; MS Contin; Ambien; Dilaudid; Vitamin B-12; Magnesium Oxide; Pseudoephedrine HCL; Vitamin E; Aspirin
Possible Thalomid side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-01
Patient: female
Reactions: Myelodysplastic Syndrome, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Lenalidomide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-04-09
End date: 2008-01-29
Cyclophosphamide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Alkeran
Indication: Multiple Myeloma
Doxorubicin HCL
Indication: Multiple Myeloma
Vincristine
Indication: Multiple Myeloma
Cisplatin
Indication: Multiple Myeloma
Thalomid
Administration route: Oral
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Possible Thalomid side effects in male
Reported by a physician from United States on 2012-01-20
Patient: male, weighing 88.5 kg (194.8 pounds)
Reactions: Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Thalomid
Possible Thalomid side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-18
Patient: 52 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Start date: 2005-06-29
Melphalan Hydrochloride
Start date: 2009-10-15
Velcade
Indication: Multiple Myeloma
Start date: 2005-06-29
Thalomid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2005-06-29
End date: 2008-07-03
Melphalan Hydrochloride
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Start date: 2005-06-29
Dexamethasone
Indication: Multiple Myeloma
Start date: 2005-06-29
End date: 2008-07-03
Doxorubicin HCL
Indication: Multiple Myeloma
Start date: 2005-06-29
Cyclophosphamide
Indication: Multiple Myeloma
Start date: 2005-06-29
Possible Thalomid side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-05
Patient: 52 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Thalomid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2005-06-29
End date: 2008-07-03
Melphalan Hydrochloride
Start date: 2009-10-15
Velcade
Indication: Multiple Myeloma
Start date: 2005-06-29
Melphalan Hydrochloride
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Start date: 2005-06-29
Dexamethasone
Indication: Multiple Myeloma
Start date: 2005-06-29
End date: 2008-07-03
Doxorubicin HCL
Indication: Multiple Myeloma
Start date: 2005-06-29
Etoposide
Indication: Multiple Myeloma
Start date: 2005-06-29
Cisplatin
Indication: Multiple Myeloma
Start date: 2005-06-29
|